Activity

A randomized, single-blind, clinical trial is underway at a single medical center. Oesophagectomy patients are randomly categorized into two groups for perioperative management: one following a goal-directed fluid therapy protocol with individualized target blood pressures, the other receiving standard care. Thirty days post-surgery, the Comprehensive Complication Index evaluates the total burden of morbidity and mortality, which is the primary endpoint. At 90 days after the surgical procedure, secondary endpoints include complications like reoperations, the dosage of fluids and vasopressors, and the patients’ quality of life.

The trial’s results offer an easily applied and objective algorithm for fluid administration in oesophagectomy, potentially leading to enhanced patient-centered outcomes.

The trial has the financial backing of both Aarhus University (1293,400 DKK) and the Novo Nordisk Foundation (625200 DKK).

The EudraCT number for this trial is given as 2021-002816-30.

The EudraCT number 2021-002816-30 corresponds to a particular entry in the EudraCT database.

For women with abnormal cervical smear results, colposcopy represents a key diagnostic step in their care. Whereas colposcopy is typically undertaken by certified colposcopists in other nations, Denmark allows colposcopy to be performed by obstetrics and gynecology (OB/GYN) residents. We sought to evaluate the quality of training in colposcopy and the loop electrosurgical excision procedure (LEEP) for Danish OB/Gyn residents.

For the training of OB/Gyn residents in colposcopy and LEEP, two questionnaires were constructed. One for residents, and one specifically designed for chief physicians, responsible for the training curriculum. In the span of November and December 2021, questionnaires were distributed through email and social media.

Ninety-three of the 120 eligible residents completed the questionnaire. The median age stood at 36 years, and the interquartile range was observed to be between 34 and 39 years. While the majority (849%) of participants received colposcopy training, a considerable number (763%) viewed it as inadequate, and reported low self-assurance in their ability to perform the procedure (720%). Regarding LEEP, a significant majority of trainees (849%) received instruction, yet nearly half (430%) felt their training inadequate and exhibited low self-confidence in executing LEEP procedures (495%).

The current training of Danish OB/Gyn residents regarding colposcopy and LEEP procedures is often substandard, thus necessitating the creation of a structured and formal training program that will adequately prepare both residents and their supervisors to deliver high-quality patient care.

The Danish Association of Young Gynecologists and Obstetricians, also known as FYGO.

Of no consequence.

This information is not applicable to the current context.

In patients with recurrent acute tonsillitis (RT) and chronic tonsillitis (CT), a Danish validated patient-reported outcome measure (PROM) for assessing throat-related quality of life is absent. We undertook the translation and linguistic validation of the Tonsillectomy Outcome Inventory 14 (TOI-14) into Danish, aiming to describe score characteristics in patients receiving radiation therapy (RT) and chemotherapy (CT) before, during, and after tonsillectomy, alongside healthy control subjects.

The ISPOR Quality of Life Special Interest Group – Translation and Cultural Adaptation group’s established guidelines for PROM translation and cultural adaptation were precisely followed by us. Elective tonsillectomy patients, categorized as RT and CT, who answered a pre-operative, postoperative, and six-month follow-up questionnaire, were included, alongside healthy controls who answered a single questionnaire.

Pursuant to the guideline, a Danish version of the TOI-14 was devised. Ultimately, the study’s final analysis involved 49 RT patients, 34 CT patients, and 67 control subjects. A substantial increase in TOI-14 scores was observed preoperatively in patients receiving radiotherapy (RT) and computed tomography (CT) treatment, markedly exceeding those in control subjects (mean total scores: RT 456; CT 217; controls 89, p < 0.0001). Following surgery, performance metrics decreased to levels comparable to control groups (RT 102, p = 0.051; CT 47, p = 0.005).

The Danish version of the TOI-14, after undergoing translation, cultural adaptation, and linguistic validation, produced comparable scores in RT, CT, and control groups to those seen in earlier German, English, and Finnish studies.

Awarded by the Lundbeck Foundation, grant number R185-2014-2482.

The Central Denmark Region’s identification number is #1-16-02-723-20.

The number 1-16-02-723-20 uniquely identifies Central Denmark Region.

From the initial reports of the mpox (formerly monkeypox) outbreak in 2022, close to half the confirmed cases in Denmark were diagnosed at the Department of Infectious Diseases within Copenhagen University Hospital – Amager and Hvidovre Hospital. stemnesskinase signaling The purpose of this article is to document the patient cohort at the Department and disseminate knowledge of mpox among colleagues, thereby potentially enhancing their identification of future cases.

A retrospective analysis of mpox cases diagnosed at the department between May 23, 2022, and February 8, 2023, documented patient characteristics, co-infections, disease presentation, and the time it took to make a diagnosis. A case report is included to underscore anorectal symptoms, featuring a hospitalized patient with severe rectal pain.

Mpox affected 86 patients, exclusively men who have sex with men, with a median age of 39 years. In this cohort study, 31% (26 patients) received pre-exposure prophylaxis for HIV, and 24% (20 patients) identified as living with HIV. A hundred percent of the patients exhibited lesions, predominantly situated on or around their genitals. Thirty-five percent of the 29 patients surveyed indicated anorectal discomfort or pain. The examination revealed chlamydia in 7 patients (10%), gonorrhoea in 19 (26%), and syphilis in 2 (5%) of the patient population. In a substantial 15% of instances (13 cases), medical professionals initially overlooked the possibility of mpox, mistakenly attributing symptoms to a co-existing gonorrhea infection. A median of three days’ hospitalization was experienced by five patients (6%).

In the event that mpox becomes endemic within Denmark, clinicians should remain vigilant concerning its symptoms and the possibility of concurrent infection with sexually transmitted infections.

None.

Does not hold any significance.

Not applicable.

The escalating rates of obesity and type 2 diabetes have become a significant global health concern, now affecting indigenous Arctic communities. In light of non-alcoholic fatty liver disease (NAFLD)’s strong ties to the metabolic syndrome, it is now a substantial cause of persistent liver issues. Yet, there is a scarcity of data on the prevalence of NAFLD in indigenous Arctic populations, who might possess a distinct risk profile concerning diabetes complications.

We comprehensively reviewed the literature to estimate the incidence of NAFLD or visible signs of NAFLD among indigenous Arctic populations residing in Greenland, Alaska, Canadian territories, and eastern Russia. A discussion of how Arctic research into metabolic diseases, specifically non-alcoholic fatty liver disease (NAFLD), might progress was our objective.

The pre-specified Ovid MEDLINE and Embase search yielded a total of 3070 unique references. From these, six studies, comprising 5487 individuals, met the criteria for data extraction. The frequency of NAFLD or the manifestation of NAFLD symptoms showed a significant disparity, spanning from 21% to 65% of the observed cases. The risk of bias was pronounced, especially considering the inclusion of small and diverse studies.

A limited body of published research addresses NAFLD in indigenous Arctic populations. This review asserts that the frequency of NAFLD or indicators of NAFLD in indigenous Arctic populations situated in Arctic regions could be comparable to the global rate, highlighting the crucial need for further health research specifically directed at these indigenous communities.

The published literature on NAFLD in indigenous Arctic populations remains notably restricted. This review’s findings indicate a possible equivalence in the prevalence of NAFLD, or signs of NAFLD, among indigenous Arctic populations within Arctic regions, with global averages, stressing the necessity for further health research in these indigenous populations.

Adults experiencing SARS-CoV-2 infection are frequently affected by olfactory dysfunction (OD). However, the presentation of symptoms in children has not been extensively studied and continues to be largely contingent upon questionnaires. The primary objectives of this study were to determine the prevalence of olfactory disorders in children infected with SARS-CoV-2 and to assess the prognostic value of olfactory testing for predicting COVID-19 in this demographic group. Moreover, we sought to explore the connection between a child’s perceived and measured olfactory senses.

For the duration of the study, from January 8th, 2022, to February 22nd, 2022, the Aarhus Test Centre invited children, aged 6-12, who were having a SARS-CoV-2 reverse transcription PCR test, to join the research. Participants underwent testing of their olfactory function, using the Sniffin’ Sticks 16 Identification Kit, and were asked about their subjective smell perception and any confounding factors present.

Among the 78 children who completed inclusion, 51 presented a positive PCR test for SARS-CoV-2. Our study failed to establish any correlation between current SARS-CoV-2 status, as measured by the Sniffin’ Sticks Identification score (p = 0.500), and self-reported prior infections. Our results included no correlation between the reported and quantified olfactory experiences (p = 0.109).

The absence of a concordance between SARS-CoV-2 infection and OD might suggest that OD is not a crucial symptom for children. Thus, olfactory testing is not a recommended screening technique for SARS-CoV-2 in adults, as previously considered.